6 nouvelles publications pour SOLADIS lors des 6 derniers mois

[mk_page_section bg_image=”/wp-content/uploads/sites/3/2017/07/clinic-specialisations.jpg” bg_position=”center top” video_loop=”false” video_opacity=”0″ min_height=”0″ full_width=”true” js_vertical_centered=”true” top_shape_color=”#ffffff” bottom_shape_color=”#ffffff” sidebar=”sidebar-1″][vc_column][mk_padding_divider size=”50″ visibility=”hidden-sm”][mk_padding_divider size=”50″ visibility=”hidden-tl”][vc_row_inner is_fullwidth_content=”false”][vc_column_inner][mk_fancy_title tag_name=”h1″ color=”#ffffff” size=”50″ force_font_size=”true” size_smallscreen=”50″ size_tablet=”50″ size_phone=”25″ font_weight=”bold” txt_transform=”uppercase” margin_bottom=”0″ font_family=”Raleway” font_type=”google”]6 nouvelles publications pour SOLADIS lors des 6 derniers mois[/mk_fancy_title][/vc_column_inner][/vc_row_inner][mk_padding_divider size=”50″ visibility=”hidden-sm”][mk_padding_divider size=”50″ visibility=”hidden-tl”][/vc_column][/mk_page_section][mk_page_section sidebar=”wptimeline-sidebar”][vc_column][vc_row_inner is_fullwidth_content=”false”][vc_column_inner][vc_empty_space height=”20px”][vc_column_text]Six nouveaux projets de recherche biomédicale de nos clients pharma et nutrition ont été publiés lors des 6 derniers mois !

Ces travaux conduits par nos équipes scientifiques nous permettent ainsi d’enregistrer nos 94ème, 95ème, 96ème, 97ème, 98ème et 99ème articles publiés.

HTRA1 activation is driven by an allosteric mechanism of inter-monomer communication.

Basophils from allergic patients are neither hyper-responsive to activation signals nor hypo-responsive to inhibition signals.

Five-year antibody persistence following a Japanese encephalitis chimeric virus vaccine (JE-CV) booster in JE-CV-primed children in the Philippines

Droplet digital PCR improves absolute quantification of viable lactic acid bacteria in faecal samples.

In-depth interviews of patients with primary immunodeficiency who have experienced pump and rapid push subcutaneous infusions of immunoglobulins reveal new insights on their preference and expectations.

A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy-associated secondary immunodeficiency

[/vc_column_text][vc_empty_space height=”20px”][/vc_column_inner][/vc_row_inner][/vc_column][/mk_page_section][vc_row fullwidth=”true”][vc_column][templatera id=”686″][/vc_column][/vc_row] READ MORE